Patents by Inventor Paul Gomes

Paul Gomes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11918573
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: March 5, 2024
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 11617749
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: April 4, 2023
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10987352
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: April 27, 2021
    Assignee: NICOX OPHTHALMICS, INC
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 10675279
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: June 6, 2018
    Date of Patent: June 9, 2020
    Assignee: NICOX OPTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9993471
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: June 12, 2018
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9750684
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: September 5, 2017
    Assignee: Nicox Ophthalmics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20170182035
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE
    Publication number: 20160106666
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 9254286
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: March 15, 2010
    Date of Patent: February 9, 2016
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark B. Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 8829005
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: September 9, 2014
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic Formulations Of Cetirizine And Methods Of Use
    Publication number: 20140045803
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: October 2, 2013
    Publication date: February 13, 2014
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic formulations of cetirizine and methods of use
    Patent number: 8569273
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: October 29, 2013
    Assignee: Aciex Therapeutics, Inc.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic Formulations of Cetirizine and Methods of Use
    Publication number: 20130252971
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: May 21, 2013
    Publication date: September 26, 2013
    Applicant: ACIEX THERAPEUTICS, INC.
    Inventors: Mark Barry Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic Formulations Of Cetirizine And Methods Of Use
    Publication number: 20110257136
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis rhinitis, and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: September 22, 2010
    Publication date: October 20, 2011
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Mark B. Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE
    Publication number: 20110105450
    Abstract: The present invention provides ophthalmic formulations of fluticasone that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic conjunctivitis in a subject in need of such treatment by topical application of the fluticasone formulations of the invention directly to the eye.
    Type: Application
    Filed: June 4, 2010
    Publication date: May 5, 2011
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Matthew J. Chapin, George Minno, Jackie Nice, Paul Gomes, Mark Barry Abelson
  • Ophthalmic Formulations of Cetirizine and Methods of Use
    Publication number: 20100240625
    Abstract: The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
    Type: Application
    Filed: March 15, 2010
    Publication date: September 23, 2010
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Mark B. Abelson, Matthew J. Chapin, Paul Gomes, George Minno, Jackie Nice
  • Ophthalmic Formulations of Ketotifen and Methods of Use
    Publication number: 20100240624
    Abstract: The present invention provides topical formulations of ketotifen that provide a comfortable formulation when instilled in the eye and are effective in the treatment and prevention of ocular allergy, particularly allergic conjunctivitis. The invention further provides methods of treating and preventing ocular allergy by in a subject in need of such treatment by topical application of the ketotifen formulations of the invention to the eye of a subject in need thereof.
    Type: Application
    Filed: February 5, 2010
    Publication date: September 23, 2010
    Applicant: Aciex Therapeutics, Inc.
    Inventors: Matthew J. Chapin, Mark B. Abelson, George Minno, Jackie Nice, Paul Gomes